Total Pharmacy |

David Pope, PharmD, Chief Pharmacy Officer at XiFin, further discussed value-based care and his company’s ongoing collaboration with pharmacies across the country.

Drug Topics sat down with Adam J. James, PharmD, to discuss learnings from his extensive experience at Rite Aid.

David Pope, PharmD, Chief Pharmacy Officer at XiFin, shared his thoughts on value-based care and how it is used within a pharmacy setting.

Jon Minkin, enterprise account executive at NimbleRx, shared how his company can help independent pharmacies unlock revenue opportunities.

Erin Albert, vice president of pharmacy relations and chief privacy officer at Mark Cuban Cost Plus Drug Company, PBC, discussed drug pricing and what her company is doing to revolutionize transparency.

In an interview with Drug Topics, TaQuina Warren, PharmD, discussed what it means to serve her community and how she has garnered a reputation within her profession.

Emily Endres, BSPS, vice president of pharmacy at PQS by Innovaccer, provides insights into the industry’s next phase.

On October 3,2024, Texas Attorney General Ken Paxton issued the lawsuit, which involves Eli Lilly, Express Scripts, CVS Pharmacy, and other pharmaceutical entities.

In an installment of Drug Topics’ 5 Questions With a Pharmacist, Anthony Minniti of Bell Pharmacy in Camden, New Jersey, discussed pharmacy in his community and the challenges that come with it.

Drug Topics sat down with Benjamin Jolley, PharmD, of Jolley’s Compounding Pharmacy, to discuss the pharmacy industry and his experience in a myriad of roles within the profession.

Adherence interventions and comprehensive reviews can reduce health care costs, boost revenue, and improve patient outcomes.

The 70-plus-page lawsuit is directed at Express Scripts for its dealings with drug manufacturers in fueling the US opioid crisis.

Medication therapy management can change the trajectory of patient health outcomes. Here is how pharmacists can ensure adherence and compensation.

A roundtable session discussed the real-world implications of applying DIR fees at the point of sale rather than through retroactive clawback.

See what’s trending in pharmacy with a preview of the Total Pharmacy October issue.

Researchers analyzed the impact of real-time prescription benefits on prescribing patterns by evaluating subsequent fill rates and copay costs.

Senators Ron Wyden and Sherrod Brown wrote a letter to the Federal Trade Commission calling to explore yet another PBM tactic impeding competition.

In an installment of Drug Topics’ 5 Questions With a Pharmacist, Lea Wolsoncroft of Remedies Pharmacy in Hoover, Alabama, discussed what is going on in her pharmacy practice.

The event will focus on innovating with cutting-edge technology, featuring the likes of pharmaceutical technology companies revolutionizing the industry.

Researchers aimed to address how community pharmacies target vulnerable groups regarding the promotion of vaccinations.

In an installment of Drug Topics’ 5 Questions With a Pharmacist, Henry and Jade Ranger of The Prescription Shoppe in Williamsburg, Virginia, discussed their practice and what it’s like operating a business together.

Johnny Garcia, Senior Director of Policy at the Pharmaceutical Care Management Association, discussed the role his company plays in the ongoing issue of rising drug prices.

Drug Topics discussed independent pharmacy advocacy and PBM reform on the state level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.

In its first move since the July interim report detailing pharmacy benefit manager practices, the FTC is now suing CVS Caremark, Express Scripts, and Optum Rx.